Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta Protein”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827768
What this trial is testing

Phase 2 Study of AV-1959R in Individuals With Preclinical Alzheimer's Disease

Who this might be right for
Preclinical Alzheimer's DiseaseAlzheimer Disease
Institute for Molecular Medicine 160
Early research (Phase 1)Not Yet RecruitingNCT07568041
What this trial is testing

Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients

Who this might be right for
Alzheimer's Disease (AD)
Cenna Biosciences Inc. 54
Testing effectiveness (Phase 2)Study completedNCT02576639
What this trial is testing

Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 124
Early research (Phase 1)Ended earlyNCT00870519
What this trial is testing

Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer's Disease
Institute for Neurodegenerative Disorders 2
Large-scale testing (Phase 3)Study completedNCT01020838
What this trial is testing

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

Who this might be right for
Alzheimer Disease
Lantheus Biosciences Ltd. 218
Testing effectiveness (Phase 2)Study completedNCT01148498
What this trial is testing

A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 55
Early research (Phase 1)Study completedNCT00765115
What this trial is testing

Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 27
Not applicableStudy completedNCT01189084
What this trial is testing

Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
United Biomedical 14
Early research (Phase 1)Not Yet RecruitingNCT07458620
What this trial is testing

Prospective Single-Arm Safety Study of Cervical LVA in AD Patients

Who this might be right for
Alzheimer's Disease (AD)
Chang Gung Memorial Hospital 35
Early research (Phase 1)Study completedNCT01138111
What this trial is testing

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

Who this might be right for
Alzheimer DiseaseAmyloid Beta-Protein
Lantheus Biosciences Ltd. 45
Large-scale testing (Phase 3)Study completedNCT00905372
What this trial is testing

Effect of LY2062430 on the Progression of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,000
Not applicableLooking for participantsNCT07623785
What this trial is testing

Assessing the Influence of Habitual Beef Intake on Key Molecular Markers of Brain Health

Who this might be right for
Healthy AgingBrain HealthCardiometabolic Health+2 more
South Dakota State University 20
Early research (Phase 1)Study completedNCT00556660
What this trial is testing

Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 20
Early research (Phase 1)Study completedNCT02360657
What this trial is testing

Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia

Who this might be right for
Alzheimer's Disease
Janssen Pharmaceutical K.K. 18
Not applicableStudy completedNCT02021682
What this trial is testing

CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Washington University School of Medicine 58
Not applicableStudy completedNCT03899844
What this trial is testing

Study to Evaluate Amyloid in Blood and Imaging Related to Dementia

Who this might be right for
Alzheimer DiseaseAlzheimer Dementia
Washington University School of Medicine 1,122
Testing effectiveness (Phase 2)Study completedNCT00088387
What this trial is testing

Effect of Lithium and Divalproex in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute of Neurological Disorders and Stroke (NINDS) 35
Early research (Phase 1)Ended earlyNCT00605046
What this trial is testing

Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 1
Not applicableNot Yet RecruitingNCT07521722
What this trial is testing

DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community

Who this might be right for
Alzheimer DiseaseCognitive Dysfunction, Cognitive DisorderDementia+1 more
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation 250
Testing effectiveness (Phase 2)Study completedNCT03354143
What this trial is testing

Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

Who this might be right for
Hypertension
University of Texas Southwestern Medical Center 85
Next Page